Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

Top 10 search results for "cancer point-lok needle" in Treatments. To see all results and access other features, sign up for free.

Did you mean cancer plant-lok needle?

Camcevi Point-Lok Needle (Leuprolide) for Prostate Cancer

 

Overview
Camcevi Point-Lok Needle is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced prostate cancer. The prescription includes a prefilled syringe with a separate needle…

read more

Camcevi SurGuard 3 Safety Needle (Leuprolide) for Prostate Cancer

Overview
Camcevi SurGuard 3 Safety Needle is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced prostate cancer. The prescription includes a prefilled syringe called the…

read more

Nubeqa (Darolutamide) for Prostate Cancer

Overview
Nubeqa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult men with nonmetastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate…

read more

Xtandi (Enzalutamide) for Prostate Cancer

Overview
Xtandi is approved by the U.S. Food and Drug Administration (FDA) to treat several forms of prostate cancer, including castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer…

read more

Erleada (Apalutamide) for Prostate Cancer

Overview
Erleada is approved by the U.S. Food and Drug Administration (FDA) to treat metastatic castration-sensitive prostate cancer (mCSPC) and nonmetastatic castration-resistant prostate cancer (nmCSPC). When taking…

read more

Talzenna (Talazoparib) for Prostate Cancer

Overview
Talzenna is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic (advanced) castration-resistant prostate cancer (mCRPC) that carries mutations (variations) in genes…

read more

Lynparza (Olaparib) for Prostate Cancer

Overview
Lynparza is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) that has either germline or somatic mutations…

read more

Zoladex (Goserelin) for Prostate Cancer

Overview
Zoladex is approved by the U.S. Food and Drug Administration (FDA) for the management of prostate cancer. It is specifically indicated for use in combination with flutamide for individuals with locally confined…

read more

Rubraca (Rucaparib) for Prostate Cancer

Overview
Rubraca is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adults who have a BRCA gene mutation (change) and who have…

read more

Firmagon (Degarelix) for Prostate Cancer

Overview
Firmagon is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer. It is used as a form of androgen deprivation therapy (ADT) to reduce testosterone levels, which…

read more